FutureFuel Corp's Q1 2025 saw a sharp revenue and profit decline due to weak biodiesel demand, regulatory uncertainty, and rising costs. The company is shifting focus to its chemical segment, pausing biodiesel production until regulatory clarity and feedstock price stability return. My fair value estimate suggests shares are trading near intrinsic value, with a 6% dividend yield providing some downside support.
FutureFuel Corp. has seen a 28% stock price decline since January, largely due to market tensions and a rough Q4. Despite the decline, FF's high cash balance relative to market cap presents a buying opportunity for risk-tolerant value investors. Its enterprise value has dropped by half during this time. FF's diversified revenue streams and stronger balance sheet set it apart from peers in the biofuel industry.
FutureFuel operates in a difficult, highly competitive industry. The company's strong balance sheet and large cash position limits downside risks for investors. FutureFuel has a long-term track-record of free-cash flow generation.
| Chemicals Industry | Materials Sector | Roeland H. Polet CEO | NYSE Exchange | 36116M106 CUSIP |
| US Country | 537 Employees | 4 Dec 2025 Last Dividend | - Last Split | 9 May 1986 IPO Date |
FutureFuel Corp., with its subsidiaries, engages in the manufacture and sale of a diversified portfolio of chemical, bio-based fuel, and bio-based specialty chemical products primarily in the United States. Operating through two main segments, Chemicals and Biofuels, the company serves a wide range of industries including coatings, industrial and consumer cleaning, oil and gas, and specialty polymers. Headquartered in Saint Louis, Missouri, FutureFuel Corp. aims to leverage its expertise in both chemical and biofuels production to deliver high-quality products that meet the evolving needs of its customers.
FutureFuel Corp. offers a broad spectrum of products and services across its Chemicals and Biofuels segments: